New trial available: Click on any alert below and access our regulatory alerts and get timely notifications sent to your inbox for 7 days.
22nd March 2023
20th February 2023
1st February 2023
23rd January 2023
Brazil: The new health minister, Nísia Trindade, has supported medical cannabis and CBD use on national television, press reports. “There is a lot of scientific evidence, and several countries around the world use it for treatments for epilepsy, Alzheimer’s and other health problems. We need the scientific evidence, the dialogue with society, to break through the prejudices and care, which is our keyword,” Trindade said.
19th December 2022
7th December 2022
Brazil: The National Public Health Surveillance Agency (Anvisa) has authorised the importation, distribution and sale of two new CBD oils: Canabidiol Hearst 200 mg/ml and Alpha Pharma 200 mg/ml.
29th November 2022
Brazil: The National Public Health Surveillance Agency (Anvisa) has authorised Canabidiol Ease Labs 100 mg/ml to be manufactured in Brazil in the form of a solution for oral use. The agency has already approved 23 cannabis-derived products.
18th November 2022
31st October 2022
25th October 2022
Brazil: The Federal Council of Medicine (CFM) has suspended a resolution restricting medical prescription of CBD after the Federal Public Prosecutor’s Office announced an investigation into its legality. The CFM left open a public consultation reviewing the resolution, which is due to end on 23rd December.
21st October 2022
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.